Paul Bhamra-Ariza and Cameron Holloway
HIV is now a chronic treatable disease, with a life expectancy approaching the general population. However, treatments with anti-retroviral medications are associated with metabolic abnormalities and an increased risk of coronary artery disease, leading to a greater incidence of cardiac morbidity and mortality. A contemporary approach to the management of patients with HIV must therefore include aggressive management of cardiovascular risk factors and appropriate screening of cardiovascular disease. This review outlines the pathogenesis of coronary disease in patients with HIV and a modern approach for screening and management.
PDFShare this article
Journal of AIDS & Clinical Research received 5061 citations as per Google Scholar report